<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38753568</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0016-3813</ISSN><JournalIssue CitedMedium="Internet"><Volume>160</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Gaceta medica de Mexico</Title><ISOAbbreviation>Gac Med Mex</ISOAbbreviation></Journal><ArticleTitle>Serum levels of anti-Ro52/TRIM21 antibodies in SARS-CoV-2 genetic variants and long COVID. Beyond their application in autoimmune diseases.</ArticleTitle><Pagination><StartPage>112</StartPage><EndPage>113</EndPage><MedlinePgn>112-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/GMM.M24000851</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elizarrar&#xe1;s-Rivas</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Research Coordination, Instituto Mexicano del Seguro Social, Oaxaca, Oaxaca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, Universidad Aut&#xf3;noma "Benito Ju&#xe1;rez de Oaxaca", Oaxaca, Oaxaca. Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramirez-Garcia</LastName><ForeName>Sergio A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Taxonomy, Faculty of Chemical Sciences, Universidad Aut&#xf3;noma "Benito Ju&#xe1;rez de Oaxaca", Oaxaca, Oaxaca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Osorio</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Taxonomy, Faculty of Chemical Sciences, Universidad Aut&#xf3;noma "Benito Ju&#xe1;rez de Oaxaca", Oaxaca, Oaxaca.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salas-Alfaro</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Social Sciences and Humanities Research Center, Universidad Aut&#xf3;noma del Estado de M&#xe9;xico, Toluca, State of Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elizarrar&#xe1;s-Cruz</LastName><ForeName>Je&#xfa;s D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Laboratory of Molecular Taxonomy, Faculty of Chemical Sciences, Universidad Aut&#xf3;noma "Benito Ju&#xe1;rez de Oaxaca", Oaxaca, Oaxaca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Surgery, Universidad Aut&#xf3;noma "Benito Ju&#xe1;rez de Oaxaca", Oaxaca, Oaxaca. Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>Niveles s&#xe9;ricos de anticuerpos anti-Ro52/TRM21 en las variantes gen&#xe9;ticas de SARS-CoV-2 en COVID prolongado. M&#xe1;s all&#xe1; de la aplicaci&#xf3;n en las enfermedades autoinmunes.</VernacularTitle></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Gac Med Mex</MedlineTA><NlmUniqueID>0010333</NlmUniqueID><ISSNLinking>0016-3813</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C035401">SS-A antigen</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012261" MajorTopicYN="Y">Ribonucleoproteins</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>16</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38753568</ArticleId><ArticleId IdType="doi">10.24875/GMM.M24000851</ArticleId><ArticleId IdType="pii">j160/1/112</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>